NIFTY HEALTHCARE Index PE Ratio
The NIFTY HEALTHCARE P/E ratio is 53.27 on a market cap weighted basis, derived from the price-to-earnings data of 20 of 20 index constituents with valid EPS. Of these, 0 stocks trade at a low P/E ratio below 15, 2 at moderate valuations between 15 and 25, 10 at elevated earnings multiples between 25 and 50, and 8 at very high valuations above 50. Analyse NIFTY HEALTHCARE index earnings to understand aggregate earnings trends across constituents. Use the NIFTY HEALTHCARE PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 20 constituents.
NIFTY HEALTHCARE PE Ratio Distribution — Low, Moderate, High & Very High
, 2 moderate (15–25), 10 high (25–50), 8 very high (50+) among 20 NIFTY HEALTHCARE stocks.
NIFTY HEALTHCARE PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY HEALTHCARE over 6 years — 20 stocks with valid EPS, current P/E 53.27. For live index level, EPS data and the full index overview, see NIFTY HEALTHCARE market index details.
NIFTY HEALTHCARE Component Stocks — P/E Ratio & EPS
20 of 20 NIFTY HEALTHCARE constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical
|
Healthcare | ₹4.6 Lakh Cr | ₹47.80 | 38.1 |
|
DIVISLAB
Divis Laboratories
|
Healthcare | ₹2.3 Lakh Cr | ₹96.75 | 77.2 |
|
TORNTPHARM
Torrent Pharmaceuticals
|
Healthcare | ₹1.9 Lakh Cr | ₹63.92 | 90.1 |
|
APOLLOHOSP
Apollo Hospitals
|
Healthcare … | ₹1.3 Lakh Cr | ₹135.04 | 58.3 |
|
CIPLA
Cipla
|
Healthcare | ₹1.1 Lakh Cr | ₹48.03 | 34.5 |
|
ZYDUSLIFE
Zydus Life Science
|
Healthcare | ₹1.1 Lakh Cr | ₹50.09 | 24.8 |
|
LUPIN
Lupin
|
Healthcare | ₹1.0 Lakh Cr | ₹116.75 | 18.3 |
|
MAXHEALTH
Max Healthcare Institute
|
Healthcare … | ₹98.7K Cr | ₹14.83 | 67.1 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹98.4K Cr | ₹16.47 | 89.2 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹98.3K Cr | ₹46.35 | 47.9 |
|
DRREDDY
Dr Reddys Laboratories
|
Healthcare | ₹97.7K Cr | ₹50.41 | 31.0 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹93.8K Cr | ₹60.34 | 26.0 |
|
FORTIS
Fortis Healthcare
|
Healthcare … | ₹68.6K Cr | ₹13.80 | 65.9 |
|
BIOCON
Biocon
|
Healthcare | ₹66.8K Cr | ₹2.82 | 162.1 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹65.7K Cr | ₹48.26 | 36.7 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹65.4K Cr | ₹192.51 | 29.2 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹56.1K Cr | ₹730.36 | 35.0 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹44.0K Cr | ₹44.98 | 32.0 |
|
GRANULES
Granules
|
Healthcare | ₹21.3K Cr | ₹24.47 | 32.1 |
|
SYNGENE
Syngene International
|
Healthcare | ₹16.4K Cr | ₹7.87 | 73.7 |
Track NIFTY HEALTHCARE PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY HEALTHCARE Trade to Journal